Cambrex Corporation, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), has expanded pilot plant capabilities at its High Point, NC, facility with the installation of a fourth reactor suite. The $2.4 million investment will increase the site’s reactor capacity by around 30%. The new 400 square-foot suite, which is being constructed to meet growing business demand, will feature two 2,000 liter reactors and a 0.6 square-meter Hastelloy filter ...